Circulating biomarkers and imaging techniques provide independent and complementary information to guide management of heart failure (HF). This consensus document by the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) presents current evidence-based indications relevant to integration of imaging techniques and biomarkers in HF. The document first focuses on application of circulating biomarkers together with imaging findings, in the broad domains of screening, diagnosis, risk stratification, guidance of treatment and monitoring, and then discusses specific challenging settings. In each section we crystallize clinically relevant recommendations and identify directions for future research. The target readership of ...
peer reviewedThe Imaging Task Force appointed by the European Society of Cardiology (ESC) and the Eu...
The approval of new heart failure (HF) therapies has slowed over the past two decades in part due to...
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) ...
Circulating biomarkers and imaging techniques provide independent and complementary information to g...
Circulating biomarkers and imaging techniques provide independent and complementary information to g...
Congestion is a cardinal sign of heart failure (HF). In the past, it was seen as a homogeneous epiph...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, p...
peer reviewedThe Imaging Task Force appointed by the European Society of Cardiology (ESC) and the Eu...
The approval of new heart failure (HF) therapies has slowed over the past two decades in part due to...
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) ...
Circulating biomarkers and imaging techniques provide independent and complementary information to g...
Circulating biomarkers and imaging techniques provide independent and complementary information to g...
Congestion is a cardinal sign of heart failure (HF). In the past, it was seen as a homogeneous epiph...
Biomarkers have dramatically impacted the way heart failure (HF) patients are evaluated and managed....
The role of biomarkers is increasingly recognized in heart failure (HF) management, for diagnosis, p...
peer reviewedThe Imaging Task Force appointed by the European Society of Cardiology (ESC) and the Eu...
The approval of new heart failure (HF) therapies has slowed over the past two decades in part due to...
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) ...